LEVINE JAMES E. (Chief Financial Officer) purchased 12.9% of their position (7.72K shares) of CARDIFF ONCOLOGY, INC. on the open market
Open‑market purchase worth $36.7K — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 12/18/2024ACC: 0000950170-24-137938
Officer· Chief Financial Officer
Since Jul 2021
+7.72K
Net shares
Net buyer
$36.7K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
7.72K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+2.56K
Price / share
$3.83
Trade value
$9.82K
% of position
4.3%
12/16/2024
60K→62.56K
Common Stock
Indirect
Shares
+2.75K
Price / share
$5.42
Trade value
$14.91K
% of position
4.4%
12/17/2024
62.56K→65.32K
Common Stock
Indirect
Shares
+2.40K
Price / share
$5.00
Trade value
$12K
% of position
3.7%
12/18/2024
65.32K→67.72K
Total
Net shares
+7.72K
Net value
$36.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/16/2024 | P · Purchase | +2.56K | $3.83 | $9.82K | 4.3% | 60K | 62.56K |
| Common Stock Indirect | 12/17/2024 | P · Purchase | +2.75K | $5.42 | $14.91K | 4.4% | 62.56K | 65.32K |
| Common Stock Indirect | 12/18/2024 | P · Purchase | +2.40K | $5.00 | $12K | 3.7% | 65.32K | 67.72K |
| Total | +7.72K | $36.73K | ||||||
Derivative Transactions0
No derivative transactions reported